Logo image
Sign in
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Journal article   Peer reviewed

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

S. A. Narod, J. S. Brunet, P. Ghadirian, M. Robson, K. Heimdal, S. L. Neuhausen, D. Stoppa-Lyonnet, C. Lerman, B. Pasini, P. de los Rios, …
Lancet, Vol.356(9245), pp.1876-1881
12/02/2000
PMID: 11130383

Metrics

5 Record Views

Details